Variant report

Variant	esv1830730
Chromosome Location	chr12:106621530-106642222
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:572)
CpG islands
(count:1098)
Chromatin interactive
region (count:45)
LncRNA
region (count:3)
Mature miRNA
region (count: 0)
miRNA target
sites (count:3)

(count:572 , 50 per page) page: 1 2 3 4 5 6 7 ... 12

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr12:106621424-106621617	HepG2	liver:	n/a	n/a
2	BACH1	chr12:106642177-106642831	H1-hESC	embryonic stem cell:	n/a	n/a
3	BCL3	chr12:106642047-106642646	A549	lung:	n/a	chr12:106642156-106642169 chr12:106642135-106642144
4	BHLHE40	chr12:106641572-106641918	GM12878	blood:	n/a	chr12:106641740-106641756
5	BHLHE40	chr12:106641123-106641230	GM12878	blood:	n/a	n/a
6	BHLHE40	chr12:106641682-106641768	K562	blood:	n/a	chr12:106641740-106641756
7	BHLHE40	chr12:106641655-106641899	HepG2	liver:	n/a	chr12:106641740-106641756
8	CCNT2	chr12:106641692-106641893	K562	blood:	n/a	n/a
9	CEBPB	chr12:106620507-106621617	A549	lung:	n/a	n/a
10	CEBPB	chr12:106620623-106621754	HepG2	liver:	n/a	n/a
11	CEBPB	chr12:106620580-106621745	A549	lung:	n/a	n/a
12	CEBPB	chr12:106621360-106621643	HepG2	liver:	n/a	n/a
13	CEBPB	chr12:106621034-106621714	MCF-7	breast:	n/a	n/a
14	CEBPB	chr12:106639649-106640022	A549	lung:	n/a	chr12:106639828-106639839 chr12:106639827-106639840
15	CEBPB	chr12:106620574-106621630	IMR90	lung:	n/a	n/a
16	CEBPB	chr12:106639683-106640014	IMR90	lung:	n/a	chr12:106639828-106639839 chr12:106639827-106639840
17	CEBPB	chr12:106621332-106621708	MCF-7	breast:	n/a	n/a
18	CEBPB	chr12:106639646-106640005	Hela-S3	cervix:	n/a	chr12:106639828-106639839 chr12:106639827-106639840
19	CEBPB	chr12:106631521-106631712	A549	lung:	n/a	chr12:106631622-106631631 chr12:106631622-106631631
20	CEBPB	chr12:106639695-106639963	HepG2	liver:	n/a	chr12:106639828-106639839 chr12:106639827-106639840
21	CEBPB	chr12:106631505-106631721	HepG2	liver:	n/a	chr12:106631622-106631631 chr12:106631622-106631631
22	CEBPB	chr12:106621350-106621747	HepG2	liver:	n/a	n/a
23	CEBPB	chr12:106639596-106640084	A549	lung:	n/a	chr12:106639828-106639839 chr12:106639827-106639840
24	CEBPB	chr12:106620572-106621750	Hela-S3	cervix:	n/a	n/a
25	CEBPB	chr12:106639807-106639998	H1-hESC	embryonic stem cell:	n/a	chr12:106639828-106639839 chr12:106639827-106639840
26	CEBPB	chr12:106621389-106621626	HepG2	liver:	n/a	n/a
27	CEBPD	chr12:106641748-106642031	HepG2	liver:	n/a	n/a
28	CEBPD	chr12:106641712-106642110	HepG2	liver:	n/a	n/a
29	CHD1	chr12:106639633-106643296	IMR90	lung:	n/a	chr12:106641025-106641035
30	CHD2	chr12:106639604-106640069	Hela-S3	cervix:	n/a	n/a
31	CHD2	chr12:106641803-106641805	HepG2	liver:	n/a	n/a
32	CHD2	chr12:106621372-106621659	Hela-S3	cervix:	n/a	n/a
33	CHD2	chr12:106640657-106641082	Hela-S3	cervix:	n/a	chr12:106641025-106641035
34	CHD2	chr12:106641823-106641890	Hela-S3	cervix:	n/a	n/a
35	CHD2	chr12:106641149-106641203	GM12878	blood:	n/a	n/a
36	CHD2	chr12:106627437-106627602	K562	blood:	n/a	n/a
37	CREB1	chr12:106641338-106642036	A549	lung:	n/a	n/a
38	CTCF	chr12:106641180-106641330	HMF	breast:	n/a	n/a
39	CTCF	chr12:106641200-106641350	GM12864	blood:	n/a	n/a
40	CTCF	chr12:106625380-106625530	A549	lung:	n/a	chr12:106625433-106625446 chr12:106625408-106625426
41	CTCF	chr12:106630619-106630690	H1-hESC	embryonic stem cell:	n/a	n/a
42	CTCF	chr12:106641200-106641350	GM12873	blood:	n/a	n/a
43	CTCF	chr12:106630557-106630756	K562	blood:	n/a	n/a
44	CTCF	chr12:106640780-106640930	AG04449	skin:	n/a	n/a
45	CTCF	chr12:106640960-106641110	AG04450	lung:	n/a	chr12:106641027-106641040
46	CTCF	chr12:106641200-106641350	Hela-S3	cervix:	n/a	n/a
47	CTCF	chr12:106641140-106641290	HMEC	breast:	n/a	n/a
48	CTCF	chr12:106641200-106641350	GM12869	blood:	n/a	n/a
49	CTCF	chr12:106641200-106641350	HEEpiC	esophagus:	n/a	n/a
50	CTCF	chr12:106641020-106641170	BJ	skin:	n/a	chr12:106641027-106641040

(count:1098 , 50 per page) page: 1 2 3 4 5 6 7 ... 22

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr12:106630712-106630762	HNPCEpiC	eye:	n/a
2	chr12:106641134-106641184	U87	brain:	n/a
3	chr12:106641994-106642044	AG04450	lung:	fetal
4	chr12:106638076-106638126	T-47D	breast:	n/a
5	chr12:106641486-106641536	A549	lung:	n/a
6	chr12:106632050-106632100	HNPCEpiC	eye:	n/a
7	chr12:106638076-106638126	NB4	blood:	n/a
8	chr12:106638076-106638126	HCPEpiC	choroid plexus:	n/a
9	chr12:106633641-106633691	GM19239	blood:	n/a
10	chr12:106626686-106626736	NH-A	brain:	n/a
11	chr12:106633440-106633490	HEK293	kidney:	embryo
12	chr12:106631875-106631925	Jurkat	blood:	n/a
13	chr12:106633641-106633691	GM12891	blood:	n/a
14	chr12:106633641-106633691	HUVEC	blood vessel:	n/a
15	chr12:106641008-106641058	SK-N-MC	brain:	n/a
16	chr12:106630712-106630762	AG09309	skin:	n/a
17	chr12:106626686-106626736	SK-N-SH_RA	brain:	n/a
18	chr12:106632050-106632100	PANC-1	pancreas:	n/a
19	chr12:106639919-106639969	GM06990	blood:	n/a
20	chr12:106626686-106626736	HIPEpiC	eye:	n/a
21	chr12:106641008-106641058	A549	lung:	n/a
22	chr12:106633938-106633988	HCPEpiC	choroid plexus:	n/a
23	chr12:106638076-106638126	NT2-D1	testis:	n/a
24	chr12:106641486-106641536	LNCaP	prostate:	n/a
25	chr12:106626686-106626736	PANC-1	pancreas:	n/a
26	chr12:106641134-106641184	HRPEpiC	eye:	n/a
27	chr12:106633524-106633574	HEEpiC	esophagus:	n/a
28	chr12:106639919-106639969	HCF	heart:	n/a
29	chr12:106631875-106631925	AG04449	skin:	fetal
30	chr12:106631875-106631925	K562	blood:	n/a
31	chr12:106631875-106631925	A549	lung:	n/a
32	chr12:106641134-106641184	GM12878	blood:	n/a
33	chr12:106633047-106633097	HEK293	kidney:	embryo
34	chr12:106641486-106641536	Hepatocyte	liver:	n/a
35	chr12:106633641-106633691	Hepatocyte	liver:	n/a
36	chr12:106626993-106627043	HepG2	liver:	n/a
37	chr12:106633524-106633574	AG09309	skin:	n/a
38	chr12:106633524-106633574	RPTEC	kidney:	n/a
39	chr12:106641008-106641058	HEK293	kidney:	embryo
40	chr12:106641486-106641536	HCM	heart:	n/a
41	chr12:106631875-106631925	U87	brain:	n/a
42	chr12:106633047-106633097	GM12892	blood:	n/a
43	chr12:106633524-106633574	AG09319	gingival:	n/a
44	chr12:106633440-106633490	SKMC	muscle:	n/a
45	chr12:106639919-106639969	BJ	skin:	n/a
46	chr12:106633524-106633574	AG10803	skin:	n/a
47	chr12:106633641-106633691	HepG2	liver:	n/a
48	chr12:106633938-106633988	T-47D	breast:	n/a
49	chr12:106633641-106633691	NB4	blood:	n/a
50	chr12:106630712-106630762	Jurkat	blood:	n/a

(count:45 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr12:106633129..106634918-chr12:106751021..106753631,2	MCF-7	breast:
2	chr12:106622227..106624483-chr12:107349565..107351095,2	K562	blood:
3	chr12:106622344..106624016-chr12:106673655..106676594,2	MCF-7	breast:
4	chr12:106640063..106644049-chr12:106694395..106698756,11	MCF-7	breast:
5	chr12:106620786..106622962-chr12:106640518..106642749,2	MCF-7	breast:
6	chr12:106625081..106625716-chr12:106675920..106676462,2	MCF-7	breast:
7	chr12:106640021..106643402-chr12:106749618..106753030,5	MCF-7	breast:
8	chr12:106639673..106643649-chr12:106748400..106753718,9	MCF-7	breast:
9	chr12:106624850..106627248-chr12:106695973..106698694,2	MCF-7	breast:
10	chr12:106622589..106625717-chr12:106638331..106640361,3	MCF-7	breast:
11	chr12:106620940..106625050-chr12:106630217..106634289,4	MCF-7	breast:
12	chr12:105500524..105503114-chr12:106640734..106642263,2	MCF-7	breast:
13	chr12:106627619..106631130-chr12:106633186..106636182,4	MCF-7	breast:
14	chr12:106628053..106629764-chr12:106751194..106753543,2	K562	blood:
15	chr12:106630802..106633610-chr12:106666760..106669656,2	MCF-7	breast:
16	chr12:106622014..106624785-chr12:106736683..106738357,2	MCF-7	breast:
17	chr12:106620792..106623041-chr12:106734428..106736723,2	MCF-7	breast:
18	chr12:106621785..106624266-chr12:106738678..106741420,2	MCF-7	breast:
19	chr12:106641570..106642137-chr12:106697112..106697741,2	MCF-7	breast:
20	chr12:106627619..106631130-chr12:106633186..106636182,4	MCF-7	breast:
21	chr12:106619967..106622887-chr12:106695577..106697877,2	MCF-7	breast:
22	chr12:106634944..106646449-chr12:106667585..106679535,27	MCF-7	breast:
23	chr12:106616826..106619612-chr12:106623488..106625547,2	K562	blood:
24	chr12:106639346..106644112-chr12:106694122..106698214,13	MCF-7	breast:
25	chr12:106620940..106625050-chr12:106630217..106634289,4	MCF-7	breast:
26	chr12:106636406..106639904-chr12:106695865..106698141,3	MCF-7	breast:
27	chr12:106626541..106632087-chr12:106638755..106642966,8	MCF-7	breast:
28	chr12:106629030..106630922-chr12:106737245..106739641,2	MCF-7	breast:
29	chr12:106630484..106633329-chr12:106636143..106637779,2	K562	blood:
30	chr12:106627724..106631160-chr12:106750781..106752959,4	MCF-7	breast:
31	chr12:106531582..106534564-chr12:106638638..106642825,4	MCF-7	breast:
32	chr12:106622589..106625717-chr12:106638331..106640361,3	MCF-7	breast:
33	chr12:106616785..106619757-chr12:106628880..106631149,2	MCF-7	breast:
34	chr12:106618176..106623447-chr12:106639085..106644031,7	MCF-7	breast:
35	chr12:106637683..106639757-chr12:106691523..106693781,3	MCF-7	breast:
36	chr12:106639693..106641308-chr12:106715072..106718036,2	MCF-7	breast:
37	chr12:106641882..106643930-chr12:106685440..106687264,2	MCF-7	breast:
38	chr12:106626663..106628634-chr12:106673414..106675622,2	MCF-7	breast:
39	chr12:106617619..106621663-chr12:106750007..106752631,4	MCF-7	breast:
40	chr12:106619722..106621935-chr12:106695466..106697508,2	MCF-7	breast:
41	chr12:106640861..106643735-chr12:106674267..106678317,3	MCF-7	breast:
42	chr12:106640559..106643459-chr12:107485293..107487296,2	K562	blood:
43	chr12:106630484..106633329-chr12:106636143..106637779,2	K562	blood:
44	chr12:106617980..106623111-chr12:106673260..106676714,5	MCF-7	breast:
45	chr12:106642113..106643655-chr12:106665361..106667243,2	MCF-7	breast:

(count:3 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-NUAK1-2	chr12:106639391-106639460	ENSG00000258355.1
2	lnc-NUAK1-5	chr12:106631814-106632649	NONHSAT030470
3	lnc-NUAK1-2	chr12:106640493-106640734	ENSG00000258355.1

No data

(count:3 , 50 per page) page: 1

No.	miRNA target gene	miRNA name	Chromosome Location
1	CKAP4	hsa-miR-7-5p	chr12:106632337-106632330
2	CKAP4	hsa-miR-30c-5p	chr12:106631732-106631754
3	CKAP4	hsa-miR-7-5p	chr12:106632331-106632353

Variant related genes	Relation type
CKAP4	TF binding region
ENSG00000258355	TF binding region
CKAP4	CpG island
ENSG00000258355	CpG island
ENSG00000136051	chromatin interactions
ENSG00000008405	chromatin interactions
ENSG00000238609	chromatin interactions
ENSG00000151135	chromatin interactions
ENSG00000013503	chromatin interactions
ENSG00000166046	chromatin interactions
ENSG00000258355	chromatin interactions
ENSG00000136026	chromatin interactions
ENSG00000257999	chromatin interactions
ENSG00000074590	chromatin interactions
ENSG00000257548	chromatin interactions

Extended variants
information (count: 980 )
Associated
traits (count: 69 )

Variant overlapped rSNPs/rCNVs (count:980 , 50 per page) page: 1 2 3 4 5 6 7 ... 20

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs7959575	chr12:106621530-106621531	Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS	Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs139866336	chr12:106621531-106621532	Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
3	rs376003996	chr12:106621532-106621533	Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
4	rs115948732	chr12:106621533-106621534	Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
5	rs192137478	chr12:106621592-106621593	Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
6	rs141591512	chr12:106621594-106621595	Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
7	rs556245806	chr12:106621595-106621596	Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
8	rs570049407	chr12:106621603-106621604	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
9	rs150781565	chr12:106621743-106621744	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
10	rs555926745	chr12:106621764-106621765	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
11	rs75381008	chr12:106621773-106621774	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
12	rs77572185	chr12:106621830-106621831	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
13	rs557932371	chr12:106621898-106621899	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
14	rs112572703	chr12:106621908-106621909	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
15	rs183961115	chr12:106621932-106621933	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
16	rs74949236	chr12:106621933-106621934	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
17	rs117587587	chr12:106621934-106621935	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
18	rs542297758	chr12:106621951-106621952	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
19	rs559062147	chr12:106621966-106621967	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
20	rs527876103	chr12:106621967-106621968	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
21	rs560999061	chr12:106621979-106621980	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
22	rs145110559	chr12:106621981-106621982	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
23	rs571034247	chr12:106622004-106622005	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
24	rs36111521	chr12:106622041-106622042	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
25	rs79563521	chr12:106622089-106622090	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
26	rs373948030	chr12:106622098-106622099	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
27	rs187578901	chr12:106622100-106622101	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
28	rs73401141	chr12:106622163-106622164	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
29	rs1215763	chr12:106622186-106622187	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
30	rs535886906	chr12:106622189-106622190	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
31	rs140582119	chr12:106622208-106622209	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
32	rs566226536	chr12:106622240-106622241	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
33	rs191510260	chr12:106622249-106622250	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
34	rs145353092	chr12:106622253-106622254	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
35	rs557631139	chr12:106622256-106622257	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
36	rs577787792	chr12:106622257-106622258	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
37	rs7297603	chr12:106622270-106622271	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
38	rs557256173	chr12:106622285-106622286	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
39	rs183023703	chr12:106622290-106622291	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
40	rs187005639	chr12:106622293-106622294	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
41	rs147657196	chr12:106622312-106622313	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
42	rs35921884	chr12:106622343-106622344	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
43	rs7297510	chr12:106622349-106622350	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
44	rs191692673	chr12:106622371-106622372	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
45	rs548579097	chr12:106622379-106622380	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
46	rs568782586	chr12:106622384-106622385	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
47	rs182071734	chr12:106622396-106622397	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
48	rs1215762	chr12:106622448-106622449	Weak transcription Enhancers	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
49	rs116363578	chr12:106622450-106622451	Weak transcription Enhancers	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
50	rs187650661	chr12:106622451-106622452	Weak transcription Enhancers	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:69)

Disease	PMID	Source
Esophageal cancer	21851588	CNVD
Lung cancer	20668451	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Ewing''s sarcoma	21437220	CNVD
Testicular germ cell tumor	18059402	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Medulloblastoma	21979893	CNVD
Malaria	21533027	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
Basal cell lymphoma	17053054	CNVD
Chronic lymphocytic leukemia	21670202	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Autism	22495311	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	21949216	CNVD
Carcinoma ex pleomorphic adenoma	18828159	CNVD
Acute myeloid leukemia	16864856	CNVD
Cancer	21637783	CNVD
Glioblastoma multiforme	21080181	CNVD
Renal cell carcinoma	19461508	CNVD
Burkitt''s lymphoma	18698080	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Gastrointestinal stromal cancer	20470368	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Lung cancer	18438408	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
small cell lung cancer	20016488	CNVD
Melanoma	18172304	CNVD
Glioblastoma multiforme	21390271	CNVD
Cancer	20164919	CNVD
Breast cancer	22032731	CNVD
Cancer	16751803	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Wilms tumour	21544195	CNVD
Ovarian cancer	21720365	CNVD
Colorectal cancer	16272173	CNVD
lymphocytic leukemia	21291569	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	17603634	CNVD
Breast cancer	16397240	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Sudden cardiac death	19188705	CNVD
Breast cancer	17133270	CNVD
Chronic lymphocytic leukemia	21049055	CNVD
Neurocytoma	17123091	CNVD
Gastrointestinal stromal cancer	20877625	CNVD
Breast cancer	21509527	CNVD
Breast cancer	21364760	CNVD
Multiple myeloma	16616336	CNVD
Myelofibrosis	22110671	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Ovarian cancer	21781307	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:1170 , 50 per page) page: 1 2 3 4 5 6 7 ... 24

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr12:106606600-106626400	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
2	chr12:106618000-106632000	Weak transcription	Brain Cingulate Gyrus	brain
3	chr12:106618000-106632200	Weak transcription	Psoas Muscle	Psoas
4	chr12:106618600-106630600	Weak transcription	Ovary	ovary
5	chr12:106618600-106632200	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
6	chr12:106620600-106621800	Enhancers	Stomach Mucosa	stomach
7	chr12:106620800-106621600	Enhancers	Liver	Liver
8	chr12:106620800-106621600	Enhancers	Skeletal Muscle Female	skeletal muscle
9	chr12:106620800-106621800	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
10	chr12:106620800-106621800	Enhancers	Breast Myoepithelial Primary Cells	Breast
11	chr12:106620800-106621800	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
12	chr12:106620800-106621800	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
13	chr12:106620800-106621800	Enhancers	Placenta	Placenta
14	chr12:106620800-106621800	Enhancers	Rectal Mucosa Donor 31	rectum
15	chr12:106620800-106622000	Enhancers	Primary B cells from peripheral blood	blood
16	chr12:106620800-106622000	Enhancers	Primary T helper cells PMA-I stimulated	--
17	chr12:106620800-106622000	Enhancers	Primary T killer memory cells from peripheral blood	blood
18	chr12:106620800-106622000	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
19	chr12:106620800-106622000	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
20	chr12:106620800-106622000	Enhancers	Fetal Heart	heart
21	chr12:106620800-106622000	Enhancers	Rectal Mucosa Donor 29	rectum
22	chr12:106620800-106622000	Enhancers	Hela-S3	cervix
23	chr12:106620800-106622000	Enhancers	NHEK	skin
24	chr12:106620800-106622200	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
25	chr12:106620800-106622200	Enhancers	Primary T cells from cord blood	blood
26	chr12:106620800-106622200	Enhancers	Primary T helper naive cells from peripheral blood	blood
27	chr12:106620800-106622200	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
28	chr12:106620800-106622200	Enhancers	Primary T regulatory cells fromperipheralblood	blood
29	chr12:106620800-106622200	Enhancers	Primary T cells effector/memory enriched fromperipheralblood	blood
30	chr12:106620800-106622200	Enhancers	HMEC	breast
31	chr12:106620800-106622400	Flanking Active TSS	Primary neutrophils fromperipheralblood	blood
32	chr12:106620800-106622400	Enhancers	Primary T cells fromperipheralblood	blood
33	chr12:106620800-106622400	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
34	chr12:106620800-106622400	Enhancers	Primary T helper cells fromperipheralblood	blood
35	chr12:106620800-106622400	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
36	chr12:106620800-106623000	Enhancers	Primary T killer naive cells fromperipheralblood	blood
37	chr12:106620800-106623200	Enhancers	Primary monocytes fromperipheralblood	blood
38	chr12:106620800-106630400	Weak transcription	Placenta Amnion	Placenta Amnion
39	chr12:106621000-106621600	Enhancers	Adipose Nuclei	Adipose
40	chr12:106621000-106621600	Weak transcription	Fetal Lung	lung
41	chr12:106621000-106621600	Enhancers	A549	lung
42	chr12:106621000-106621800	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
43	chr12:106621000-106621800	Enhancers	Muscle Satellite Cultured Cells	--
44	chr12:106621000-106621800	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
45	chr12:106621000-106621800	Enhancers	Esophagus	oesophagus
46	chr12:106621000-106621800	Enhancers	Fetal Thymus	thymus
47	chr12:106621000-106621800	Enhancers	Gastric	stomach
48	chr12:106621000-106621800	Enhancers	Spleen	Spleen
49	chr12:106621000-106621800	Enhancers	HSMMtube	muscle
50	chr12:106621000-106622000	Flanking Active TSS	Monocytes-CD14+_RO01746	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links